Literature DB >> 25047855

Collateral vessel number, plaque burden, and functional decline in peripheral artery disease.

Mary M McDermott1, James Carr2, Kiang Liu2, Christopher M Kramer3, Chun Yuan4, Lu Tian5, Michael H Criqui6, Jack M Guralnik7, Luigi Ferrucci8, Lihui Zhao2, Dongxiang Xu9, Melina Kibbe10, Jarett Berry11, Timothy J Carroll2.   

Abstract

Associations of collateral vessels and lower extremity plaque with functional decline are unknown. Among people with peripheral artery disease (PAD), we determined whether greater superficial femoral artery (SFA) plaque burden combined with fewer lower extremity collateral vessels was associated with faster functional decline, compared to less plaque and/or more numerous collateral vessels. A total of 226 participants with ankle-brachial index (ABI) <1.00 underwent magnetic resonance imaging of lower extremity collateral vessels and cross-sectional imaging of the proximal SFA. Participants were categorized as follows: Group 1 (best), maximum plaque area < median and collateral vessel number ≥6 (median); Group 2, maximum plaque area < median and collateral vessel number <6; Group 3, maximum plaque area > median and collateral vessel number ≥6; Group 4 (worst), maximum plaque area > median and collateral vessel number <6. Functional measures were performed at baseline and annually for 2 years. Analyses adjust for age, sex, race, comorbidities, and other confounders. Annual changes in usual-paced walking velocity were: Group 1, +0.01 m/s; Group 2, -0.02 m/s; Group 3, -0.01 m/s; Group 4, -0.05 m/s (p-trend=0.008). Group 4 had greater decline than Group 1 (p<0.001), Group 2 (p=0.029), and Group 3 (p=0.010). Similar trends were observed for fastest-paced 4-meter walking velocity (p-trend=0.018). Results were not substantially changed when analyses were repeated with additional adjustment for ABI. However, there were no associations of SFA plaque burden and collateral vessel number with decline in 6-minute walk. In summary, a larger SFA plaque burden combined with fewer collateral vessels is associated with a faster decline in usual and fastest-paced walking velocity in PAD.
© The Author(s) 2014.

Entities:  

Keywords:  atherosclerotic plaque; intermittent claudication; peripheral artery disease; physical functioning

Year:  2014        PMID: 25047855      PMCID: PMC4317389          DOI: 10.1177/1358863X14540362

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  30 in total

1.  Generalized autocalibrating partially parallel acquisitions (GRAPPA).

Authors:  Mark A Griswold; Peter M Jakob; Robin M Heidemann; Mathias Nittka; Vladimir Jellus; Jianmin Wang; Berthold Kiefer; Axel Haase
Journal:  Magn Reson Med       Date:  2002-06       Impact factor: 4.668

2.  Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.

Authors:  Robert J Lederman; Farrell O Mendelsohn; R David Anderson; Jorge F Saucedo; Alan N Tenaglia; James B Hermiller; William B Hillegass; Krishna Rocha-Singh; Thomas E Moon; M J Whitehouse; Brian H Annex
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

3.  Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease.

Authors:  Sanjay Rajagopalan; Jeffrey W Olin; Stuart Young; Marlena Erikson; Paul M Grossman; Farrell O Mendelsohn; Judith G Regensteiner; William R Hiatt; Brian H Annex
Journal:  Hum Gene Ther       Date:  2004-06       Impact factor: 5.695

Review 4.  Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion.

Authors:  Matthew A Ziegler; Matthew R Distasi; Randall G Bills; Steven J Miller; Mouhamad Alloosh; Michael P Murphy; A George Akingba; Michael Sturek; Michael C Dalsing; Joseph L Unthank
Journal:  Microcirculation       Date:  2010-01       Impact factor: 2.628

5.  Use of synchrotron radiation microangiography to assess development of small collateral arteries in a rat model of hindlimb ischemia.

Authors:  S Takeshita; T Isshiki; H Mori; E Tanaka; K Eto; Y Miyazawa; A Tanaka; Y Shinozaki; K Hyodo; M Ando; M Kubota; K Tanioka; K Umetani; M Ochiai; T Sato; H Miyashita
Journal:  Circulation       Date:  1997-02-18       Impact factor: 29.690

6.  Superficial femoral artery plaque, the ankle-brachial index, and leg symptoms in peripheral arterial disease: the walking and leg circulation study (WALCS) III.

Authors:  Mary M McDermott; Kiang Liu; James Carr; Michael H Criqui; Lu Tian; Debiao Li; Luigi Ferrucci; Jack M Guralnik; Christopher M Kramer; Chun Yuan; Melina Kibbe; William H Pearce; Jarett Berry; Walter McCarthy; Yihua Liao; Dongxiang Xu; Jennifer Orozco; Timothy J Carroll
Journal:  Circ Cardiovasc Imaging       Date:  2011-03-24       Impact factor: 7.792

7.  Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases.

Authors:  Ramin Shadman; Michael H Criqui; Warner P Bundens; Arnost Fronek; Julie O Denenberg; Anthony C Gamst; Mary M McDermott
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

8.  Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.

Authors:  Sanjay Rajagopalan; Emile R Mohler; Robert J Lederman; Farrell O Mendelsohn; Jorge F Saucedo; Corey K Goldman; John Blebea; Jennifer Macko; Paul D Kessler; Henrik S Rasmussen; Brian H Annex
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

9.  Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.

Authors:  Mary McGrae McDermott; Kiang Liu; Philip Greenland; Jack M Guralnik; Michael H Criqui; Cheeling Chan; William H Pearce; Joseph R Schneider; Luigi Ferrucci; Lillian Celic; Lloyd M Taylor; Ed Vonesh; Gary J Martin; Elizabeth Clark
Journal:  JAMA       Date:  2004-07-28       Impact factor: 56.272

10.  Prognostic value of functional performance for mortality in patients with peripheral artery disease.

Authors:  Mary M McDermott; Lu Tian; Kiang Liu; Jack M Guralnik; Luigi Ferrucci; Jin Tan; William H Pearce; Joseph R Schneider; Michael H Criqui
Journal:  J Am Coll Cardiol       Date:  2008-04-15       Impact factor: 24.094

View more
  3 in total

1.  Plaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease Events.

Authors:  Mary M McDermott; Christopher M Kramer; Lu Tian; James Carr; Jack M Guralnik; Tamar Polonsky; Timothy Carroll; Melina Kibbe; Michael H Criqui; Luigi Ferrucci; Lihui Zhao; Daniel S Hippe; John Wilkins; Dongxiang Xu; Yihua Liao; Walter McCarthy; Chun Yuan
Journal:  JACC Cardiovasc Imaging       Date:  2016-11-09

Review 2.  With a Little Help From My Friends: the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease.

Authors:  Jakob Nyvad; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2022-02-09       Impact factor: 10.190

3.  Femoral artery plaque characteristics, lower extremity collaterals, and mobility loss in peripheral artery disease.

Authors:  Mary M McDermott; Timothy Carroll; James Carr; Chun Yuan; Luigi Ferrucci; Jack M Guralnik; Melina Kibbe; Michael H Criqui; Lu Tian; Tamar Polonsky; Lihui Zhao; Ying Gao; Daniel S Hippe; Dongxiang Xu; Walter McCarthy; Christopher M Kramer
Journal:  Vasc Med       Date:  2017-09-30       Impact factor: 3.239

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.